Results 121 to 130 of about 26,491 (207)

Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects. [PDF]

Pharmacogenomics J
Eijsbouts C, Jiang Y, Ashenhurst JR, Granka JM, 23andMe Research Team, Pitts S, Auton A, Abul-Husn NS, Chubb A, Wu RR.   +9 more
europepmc   +1 more source

Anomaly detection as a tool for identifying cases of interest in postmortem toxicology. [PDF]

Sci Rep
Söderberg C, Sysoev O, Magnusson R, Kugelberg FC, Green H.   +4 more
europepmc   +1 more source

Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders. [PDF]

Eur J Clin Pharmacol
Hersleth V, Spigset O, Weider S, Koch E, Andreassen OA, Lydersen S, Fjukstad KK.   +6 more
europepmc   +1 more source

Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19

, 2009
Citalopram is marketed as a racemate (50:50) mixture of the S(+)-enantiomer and R(-)-enantiomer and the active S(+)-enantiomer (escitalopram) that possess inhibitory effects.
Bengtsson, Finn,, Ahlner, Johan,, Holmgren, A.,, Carlsson, Björn,   +3 more
core  

Efficacy of Antidepressants in Treating Functional Abdominal Pain Disorders in Children: A Meta-Analysis of Randomized Controlled Trials. [PDF]

Pediatr Gastroenterol Hepatol Nutr
Kim YJ, Kim NW, Park SH, Jung HY.
europepmc   +1 more source

Sex-based Differences in the Efficacy and Tolerability of Selective Serotonin Reuptake Inhibitors in Adults with Major Depressive Disorder: A Systematic Review and Meta-analysis. [PDF]

Indian J Psychol Med
Pandey AK, Tiwary A, Khan FA, Reyazudin M, Khan IA.   +4 more
europepmc   +1 more source

Evaluating <i>Caenorhabditis elegans</i> as a Toxicity Model for Reuptake Inhibitors. [PDF]

MicroPubl Biol
Hernandez CE, Van Stone A, So C.
europepmc   +1 more source

Citalopram-induced photopigmentation. [PDF]

JAAD Case Rep
Kaufman L, Batta S, Mohamed N, Fiala K.
europepmc   +1 more source

Early effects of a novel 5-HT₄R agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: RESTAND study. [PDF]

Br J Psychiatry
Gillespie AL, de Cates AN, Scaife J, Blandhol M, Martens MAG, Gibson D, Godlewska BR, Howard W, Cowen PJ, Murphy SE, Harmer CJ.   +10 more
europepmc   +1 more source

Frailty, polypharmacy, deprescribing, and 23-hour activity: insights from a mouse model. [PDF]

J Gerontol A Biol Sci Med Sci
Mach J, Winardi K, Hilmer SN.
europepmc   +1 more source